Colorectal Cancer Screening and Quality Measures
Statistics and Industry Challenges
Colorectal cancer is the third most commonly diagnosed cancer in the U.S. and the third leading cause of cancer death in both men and women. The majority of these cancers and deaths can be prevented.
Screening Programs Lead to Prevention and Early Detection
In the past decade, there has been steady progress in reducing the incidence of colorectal cancer, with a consequent increase in survival rates. This progress has largely been the result of screening. However, in one study by the American Cancer Society, only 59 percent of people age 50 or older reported having received colorectal cancer testing consistent with current guidelines.
Streamlining the Colorectal Screening Process
Conducting population health screening programs is a multi-step process. BioIQ has developed a healthcare quality platform that automates this entire cycle. Participating organizations simply supply an eligibility file containing information about members who are out of compliance. BioIQ initiates an at-home screening program and implements a robust engagement campaign to increase compliance.